277 related articles for article (PubMed ID: 16376846)
21. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
22. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
[TBL] [Abstract][Full Text] [Related]
23. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
Gray J; Fullarton GM
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
[TBL] [Abstract][Full Text] [Related]
24. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Cooper BT; Chapman W; Neumann CS; Gearty JC
Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
[TBL] [Abstract][Full Text] [Related]
25. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
Thomas T; Richards CJ; de Caestecker JS; Robinson RJ
Aliment Pharmacol Ther; 2005 Mar; 21(6):747-55. PubMed ID: 15771761
[TBL] [Abstract][Full Text] [Related]
26. [Barrett's oesophagus: place of antireflux surgery].
Mabrut JY; Baulieux J
Ann Chir; 2006 Mar; 131(3):177-82. PubMed ID: 16527242
[TBL] [Abstract][Full Text] [Related]
27. Technology insight: ablative techniques for Barrett's esophagus--current and emerging trends.
Johnston MH
Nat Clin Pract Gastroenterol Hepatol; 2005 Jul; 2(7):323-30. PubMed ID: 16265286
[TBL] [Abstract][Full Text] [Related]
28. [Argon plasma coagulation in Barrett's esophagus].
Nomura T; Yamashita K; Miyashita M; Tajiri T
Nihon Rinsho; 2005 Aug; 63(8):1458-62. PubMed ID: 16101240
[TBL] [Abstract][Full Text] [Related]
29. Surgical treatment of esophageal high-grade dysplasia.
Reed MF; Tolis G; Edil BH; Allan JS; Donahue DM; Gaissert HA; Moncure AC; Wain JC; Wright CD; Mathisen DJ
Ann Thorac Surg; 2005 Apr; 79(4):1110-5; discussion 1110-5. PubMed ID: 15797034
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
[TBL] [Abstract][Full Text] [Related]
31. Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence.
Ferraris R; Fracchia M; Foti M; Sidoli L; Taraglio S; Vigano' L; Giaccone C; Rebecchi F; Meineri G; Senore C; Pera A;
Aliment Pharmacol Ther; 2007 Apr; 25(7):835-40. PubMed ID: 17373922
[TBL] [Abstract][Full Text] [Related]
32. Barrett's oesophagus: optimal strategies for prevention and treatment.
Fass R; Sampliner RE
Drugs; 2003; 63(6):555-64. PubMed ID: 12656653
[TBL] [Abstract][Full Text] [Related]
33. [New advances in the diagnosis and treatment of early onset dysplasia and adenocarcinoma in Barrett's oesophagus].
Pera M; Grande L; Iglesias M; Ramón JM; Conio M
Cir Esp; 2009 Jun; 85(6):331-40. PubMed ID: 19463990
[TBL] [Abstract][Full Text] [Related]
34. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia.
Wolfsen HC
Expert Rev Med Devices; 2005 Nov; 2(6):713-23. PubMed ID: 16293098
[TBL] [Abstract][Full Text] [Related]
35. Laser ablation therapies for Barrett's esophagus.
Abbas G; Pennathur A; Keeley SB; Landreneau RJ; Luketich JD
Semin Thorac Cardiovasc Surg; 2005; 17(4):313-9. PubMed ID: 16428037
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.
Overholt BF; Lightdale CJ; Wang KK; Canto MI; Burdick S; Haggitt RC; Bronner MP; Taylor SL; Grace MG; Depot M;
Gastrointest Endosc; 2005 Oct; 62(4):488-98. PubMed ID: 16185958
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.
Pohl H; Sonnenberg A; Strobel S; Eckardt A; Rösch T
Gastrointest Endosc; 2009 Oct; 70(4):623-31. PubMed ID: 19394011
[TBL] [Abstract][Full Text] [Related]
38. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
[TBL] [Abstract][Full Text] [Related]
39. High-grade dysplasia in Barrett's oesophagus.
Wright TA
Br J Surg; 1997 Jun; 84(6):760-6. PubMed ID: 9189080
[TBL] [Abstract][Full Text] [Related]
40. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?
Konda VJ; Ross AS; Ferguson MK; Hart JA; Lin S; Naylor K; Noffsinger A; Posner MC; Dye C; Cislo B; Stearns L; Waxman I
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):159-64. PubMed ID: 18096439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]